Getting AstraZeneca COVID-19 vaccine was the right choice, Guelph’s public health unit says

The public health unit for the city of Guelph says those who received an Oxford-AstraZeneca COVID-19 vaccine made the right choice.

Wellington-Dufferin-Guelph Public Health released that reassuring message in a statement on Thursday, days after the province announced it was pausing the use of the vaccine.

Read more:
Ontario pausing use of AstraZeneca COVID-19 vaccine due to safety, supply concerns

At least 20,000 people locally received AstraZeneca during the vaccination rollout.

“Getting AstraZeneca means you were vaccinated earlier than you would have been had you waited for another vaccine,” said Dr. Matthew Tenenbaum, associate medical officer of health.

“That protected you and the people around you from COVID-19 and helped move our community toward the end of this pandemic.”

Story continues below advertisement


Click to play video: 'COVID-19: Mixed messaging around AstraZeneca vaccine highlights public distrust, uncertainty'







COVID-19: Mixed messaging around AstraZeneca vaccine highlights public distrust, uncertainty


COVID-19: Mixed messaging around AstraZeneca vaccine highlights public distrust, uncertainty

The government announced on Tuesday that it is pausing the use of the AstraZeneca vaccine due to safety and supply issues.

Dr. David Williams, Ontario’s chief medical officer of health, said the decision was made out of an abundance of caution because of increased instances of an extremely rare and potentially fatal blood clotting disorder, vaccine-induced immune thrombotic thrombocytopenia (VITT), linked to the shot.

“We are reviewing the data to consider options for the use of the AstraZeneca vaccine for second doses and more broadly moving forward,” he told reporters Tuesday afternoon.

Read more:
Risk of blood clots appears ‘even more rare’ on 2nd AstraZeneca dose: experts

In Canada, at least 12 VITT cases have been confirmed out of more than two million doses given and three women have died. In Ontario as of May 8, there were eight VITT cases reported after approximately 901,800 Oxford-Astrazeneca doses were administered.

Story continues below advertisement

Tenenbaum said anyone who develops symptoms such as persistent and severe headaches, seizures, blurred vision or shortness of breath should contact their doctor or go to the emergency department immediately.

“No one wants to hear that a medical treatment they’ve received might put them at risk. But, the surveillance system has done what it is supposed to do — take new scientific information and adapt our practices accordingly,” he said.


Click to play video: 'Trudeau says doctor recommended he get 2nd AstraZeneca COVID-19 vaccine dose'







Trudeau says doctor recommended he get 2nd AstraZeneca COVID-19 vaccine dose


Trudeau says doctor recommended he get 2nd AstraZeneca COVID-19 vaccine dose

Tenenbaum couldn’t say what this means for those who received a shot of AstraZeneca and are waiting for a second dose.

Read more:
Nearly 255K doses of AstraZeneca to arrive in Ontario next week, to be used as 2nd shots

“I know many of you now have concerns about what this means for your second dose,” he said.

Story continues below advertisement

“Please rest assured we will follow provincial and federal direction on future vaccinations, guided by the best and most up-to-date information.”




© 2021 Global News, a division of Corus Entertainment Inc.

About admin

Check Also

Halifax teachers breathe a ‘sigh of relief’ over shift to online learning, union president says

Quebec adds more than 550 new COVID-19 cases, 8 more deaths

Quebec is reporting 551 new cases and eight more deaths, including two in the …